BPS3232 Molecular basis of drug action
Faculty of Pharmacy and Pharmaceutical Sciences
BPS3232 Molecular basis of drug action is a level 3, 6-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2020 in Semester 2 at Parkville. It needs BPS2011 and BPS2021.
- Credit points
- 6
- Offered in 2020
- Semester 2
- Parkville
- Assessment
- Exam 40%
- and 3 other tasks
The 2027 handbook has no page for BPS3232. This is its 2020 entry, the latest one.
Reviews
No reviews yetNo reviews yet. Be the first to review BPS3232.
Requisites
Before BPS3232
Prerequisites
Pass these before you enrol.
After BPS3232
No unit lists BPS3232 as a prerequisite in the 2020 handbook.
Overview
This unit will introduce students to the different mechanisms of action by which drugs exert their biological activity. It will address the interactions between endogenous ligands and drugs with their receptors, enzymes or nucleic acids, and the way that drugs mimic, oppose or modify those interactions. Students will be introduced to the scope of medicinal chemistry techniques used in contemporary drug discovery.
This will involve the study of:
- G-protein coupled receptors
- other receptor types
- ion channels
- nuclear hormone receptors
- drugs interacting with oligonucleotides
- enzymes and enzyme inhibition
Students in the unit will undertake a significant team-based inquiry project that reflects the role of medicinal chemistry in the drug discovery, design and development process.
Offerings in 2020
| Teaching period | Campus | Mode |
|---|---|---|
| Second semester | Parkville | On campus |
Assessment
- Poster presentation25%
- Workshops15%
- Mid-Semester test20%
- End-of-semester exam40%
Learning outcomes
When you finish this unit, you should be able to:
- 1
Explain central concepts relating to the interaction of endogenous ligands, drugs and therapeutic targets, including:
- Common receptor classes, agonism/antagonism, inverse agonism and allosteric modulation
- Enzyme classes including metalloenzymes, their reactions and kinetic properties, and enzyme inhibition
- DNA oligonucleotide recognition and modification by ligands
- Peptidomimetics
- Small molecule structure-activity relationships
- 2
Apply common design approaches (ligand-based, structure-based and mechanism-based design strategies) to propose drug molecules for therapeutic targets
- 3
Acquire skills in researching information and to present the findings in a structured, logical and fluent manner;
- 4
Effectively work in a team to plan, conduct and complete an inquiry project.
Workload and teaching
- Lectures16 hours
- Workshops24 hours
- Eight x1.5-hour online modules (discovery)
- Sixteen x1-hour interactive lectures
- Eight x3-hour workshops
Learning resources
Technology resources
For more information on Bring Your Own Device (BYOD) specifications and the technology systems and services available to students, review the Student Technology Essentials Handbook https://www.monash.edu/__data/assets/pdf_file/0010/1041220/student-it-brochure.pdf
Contacts
- Chief Examiners
- Dr Tony Hughes
- Unit Coordinators
- Dr Tony Hughes
Common questions
More details
- Credit points
- 6
- Level
- 3
- Study level
- Undergraduate
- Faculty
- Faculty of Pharmacy and Pharmaceutical Sciences
- Type
- Coursework
- EFTSL
- 0.125
- Student contribution
- SCA Band 2
- Study abroad
- Not available
- Handbook years
- 2020